Health

Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg

– Both pivotal studies achieved primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies with high statistical significance (p<0.0001) – Approximately 50% of patients in BROADWAY (Obicetrapib monotherapy) and  over 70% of patients in TANDEM (Fixed Do...

2024-12-16 22:08 1574

World's 1st Stem Cell Book on Animals, Reveals How to Extend the Lives of Pets

KOTA KINABALU, Malaysia, Dec. 16, 2024 /PRNewswire/ -- A groundbreaking new book by Professor Dr.Mike Chan, "STEM CELLS, PEPTIDES & IMMUNOTHERAPY: Handbook on Regenerative Medicine for Animals," introduces revolutionary ...

2024-12-16 22:00 2235

Everise Expands and Diversifies Its Healthcare Services Portfolio With the Acquisition of Continuum Global Solutions' Vertical

The acquisition strengthens Everise's position as a leading end-to-end healthcare experience provider PLANTATION, Fla., Dec. 16, 2024 /PRNewswire/ -- Everise, a global healthcare customer experience leader, today announced the successful completion of its acquisition of customer experience manag...

2024-12-16 21:00 2793

Nona Biosciences Announces Discovery Collaboration with Candid Therapeutics for Next-Generation T-Cell Engagers

CAMBRIDGE, Mass., Dec. 16, 2024 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM ), today announced a research collaboration and license agreement to discover next-generation T-cell engagers ("TCEs") with Candid Therapeutics, ...

2024-12-16 20:03 917

Perennial General Hospital Tianjin, China's First Wholly Foreign-Owned Private Tertiary General Hospital Will Soon Commence Operations

SINGAPORE, Dec. 16, 2024 /PRNewswire/ -- Perennial Holdings Private Limited (" Perennial Holdings") is pleased to announce that Perennial General Hospital in Tianjin city ("Perennial General Hospital Tianjin"), China, has become the country's first wholly foreign-owned private tertiary general hos...

2024-12-16 19:37 2335

Fangzhou Inc. Garners Prestigious "Most Valued Pharmaceutical & Healthcare Enterprise" Award

SHENZHEN, China, Dec. 16, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, was honored with a "Most Valued Pharmaceutical & Healthcare Enterprise" award at the grand "9th Zhitong Finance Capital Market Summit and Listed Compan...

2024-12-16 18:13 1260

Meeting Baby's Nutritional Needs: Exploring How a2 Milk Powder Enhances Absorption

SHANGHAI, Dec. 16, 2024 /PRNewswire/ -- The a2® Platinum Milk Powder has been upgraded, signifying the brand's continuous innovation and progress in the field of infant nutrition. The a2®Milk Limited, a premium brand in dairy nutrition, focuses on products containing the A2 beta-casein type, anno...

2024-12-16 18:05 1225

HKBU biologists discover two new windowpane shell species

HONG KONG, Dec. 16, 2024 /PRNewswire/ -- Biologists from Hong Kong Baptist University (HKBU) have discovered two new species of windowpane shell at Mai Po, Hong Kong and in the South China Sea. Also known as the windowpane oyster or capiz shell, the windowpane shell is a small group of saltwater ...

2024-12-16 16:37 1068

HiRO Forges Strategic Partnership with CHA University Bundang Medical Center in South Korea

SEOUL, South Korea, Dec. 16, 2024 /PRNewswire/ -- Harvest Integrated Research Organization (HiRO), a boutique globalclinical research organization (CRO) providing cross-border clinical trial solutions, proudly announces the signing of a Memorandum of Understanding (MOU) with CHA University Bundan...

2024-12-16 10:30 1666

Seoul to Host 1,040㎡ 'Seoul Pavilion' at CES 2025: "Advancing Global Success for Seoul Startups"

SEOUL, South Korea, Dec. 15, 2024 /PRNewswire/ -- The Seoul Metropolitan Government announced onDecember 9 that it will operate its largest-ever exhibition space forSeoul-based startups at CES 2025, the world's largest consumer electronics and ICT trade show. The event will run fromJanuary 7 to ...

2024-12-16 09:21 1486

Take Charge of Your Health with Genuine USANA Products

SALT LAKE CITY, Dec. 16, 2024 /PRNewswire/ -- USANA Health Sciences is a leader in providing quality health supplements, foods and energy products, and skincare solutions to customers around the world. Unfortunately, counterfeit USANA products may find their way to online retailers that do not ca...

2024-12-16 08:46 1023

Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca® (pirtobrutinib) in Mainland China

SAN FRANCISCO and SUZHOU, China, Dec. 16, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...

2024-12-16 07:55 2290

Take Charge of Your Health with Genuine USANA Products

SALT LAKE CITY, Dec. 16, 2024 /PRNewswire/ -- USANA Health Sciences is a leader in providing quality health supplements, foods and energy products, and skincare solutions to customers around the world. Unfortunately, counterfeit USANA products may find their way to online retailers that do not ca...

2024-12-16 07:47 1010

Arsana Foundation Collaborates with Om Ham Retreat & Resort to Launch Transformative 200hr Kundalini Tantra Yoga Teacher Training in 2025

BALI, Indonesia, Dec. 16, 2024 /PRNewswire/ -- Arsana Foundation  is proud to announce its partnership withOm Ham Retreat & Resort  to introduce a life-changing opportunity for individuals seeking to unlock the...

2024-12-16 07:00 2277

Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry Through Consistent Quality Assurance, On-time Delivery, Sustainability, and Competitive Costs

Bushu Pharma's ongoing investments and efforts offer customers state-of-the-art capabilities, increased capacity, and innovative solutions, providing top-tier pharmaceutical manufacturing and supply chain management services. SAN ANTONIO, Dec. 15, 2024 /PRNewswire/ -- Frost & Sullivan researched ...

2024-12-15 13:30 1862

China Pharma Announces the Entry of "At-The-Market" Equity Offering

HAIKOU, China, Dec. 13, 2024 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," or the "Company"), a specialty pharmaceutical company, today announced that it has filed a prospectus supplement with the U.S. Securities and Exchange Commission (the "SEC") under which...

2024-12-13 21:00 2925

Young International Scientists Say: China-Myanmar Partnership Advances Agricultural Innovation

BEIJING, Dec. 13, 2024 /PRNewswire/ -- Mango, a tropical fruit rich in nutrients, has a vital position in Myanmar's agriculture.Myanmar researcher Nann Miky Moh Moh worked with Chinese scientists at Zhejiang University in east China on genetically improving the flavor and variety of the fruit. ...

2024-12-13 18:21 1241

Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101

* Company to conduct a Phase II multi-regional clinical trial (MRCT) for the treatment of Ulcerative Colitis (UC) * A Phase Ib Study of AC-101 for Ulcerative Colitis (UC) has been initiated in China * AC-101 demonstrated a favorable safety and PK/PD profile in healthy volunteers in Phase Ia ...

2024-12-13 12:57 1290

Alphamab Oncology Presented the Phase II Clinical Data of KN046 in Combination with Axitinib for the Treatment of Advanced NSCLC at ESMO IO Congress 2024

SUZHOU, China, Dec. 13, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the latest clinical data from a phase II clinical study on PD-L1/CTLA-4 bispecific antibody KN046 in combination with axitinib as first-line treatment for advanced non-small cell lung cancer (NSCLC...

2024-12-13 10:35 2228

Heranova to Unveil HerResolve™, a Revolutionary Non-Invasive Endometriosis Test, at the Ovarian Club Asian Conference in Hong Kong

92% Diagnostic Accuracy with a Simple Blood Test for Early Diagnosis and Treatment of Endometriosis HONG KONG, Dec. 13, 2024 /PRNewswire/ -- Heranova, a leader in women's health innovation, is excited to announce the launch of HerResolve™, a groundbreaking non-invasive test for endometriosis, at...

2024-12-13 08:00 2294
1 ... 10111213141516 ... 872